If you have been reading about AOD-9604 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-11-04. Numbers and descriptions here follow the published literature rather than marketing material.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
== External links == Research group which presented initial claims of hafnium nuclear isomer de-excitation control. Archived 25 February 2009 at the Wayback Machine – The Center for Quantum Electronics, The University of Texas at Dallas. JASON Defense Advisory Group report on high energy nuclear materials mentioned in the Washington Post story above Bertram Schwarzschild (May 2004). "Conflicting Results on a Long-Lived Nuclear Isomer of Hafnium Have Wider Implications". Physics Today. 57 (5): 21–24. Bibcode:2004PhT....57e..21S. doi:10.1063/1.1768663. Confidence for Hafnium Isomer Triggering in 2006. – The Center for Quantum Electronics, The University of Texas at Dallas. Reprints of articles about nuclear isomers in peer reviewed journals. – The Center for Quantum Electronics, The University of Texas at Dallas.
== Media portrayals == The Edge of Love, 2008 film with Thomas portrayed by Matthew Rhys and his wife, Caitlin, played by Sienna Miller. Set Fire to the Stars, 2014 film with Thomas portrayed by Celyn Jones and John Brinnin by Elijah Wood. Dominion, 2017 film with Thomas played by Rhys Ifans and Caitlin portrayed by Romola Garai.
The fund's devolution to union territories by the union government has no criteria where all the revenue goes to the union government. Some union territories are provided more funds, while others are given less, arbitrarily by the union government. As union territories are directly ruled by the union government, some union territories get more funds from the union government than entitled on per capita and backwardness basis when compared to states. After the introduction of GST, UT-GST is applicable in union territories that do not have a legislative assembly. UT-GST is levied at par with the applicable state GST in the rest of the country which would eliminate the previous lower taxation in the union territories.
Thomas Lectka is an American organic chemist, academic and researcher. He is Jean and Norman Scowe Professor of Chemistry and leads the Lectka Group at Johns Hopkins University. Lectka specializes in areas of catalysis in synthetic and mechanistic organic chemistry and has authored over 120 research publications. He has made contributions in the discovery of metal-catalyzed amide isomerization; the development of first practical method for the catalytic, asymmetric synthesis of beta-lactams; the synthesis of [C-F-C] fluoronium ions; and site-selective aliphatic fluorination.
Its remaining inhabitants built and manned anti-tank defenses, while the city was bombarded from the air. On 1 May 1944, a Medal "For the Defence of Moscow" was instituted; in 1947, a Medal "In Commemoration of the 800th Anniversary of Moscow" was instituted. German and Soviet casualties during the battle have been debated, as sources provide different estimates. Total casualties between 30 September 1941 and 7 January 1942 are estimated at 248,000–400,000 for the Wehrmacht and 650,000–1,280,000 for the Red Army.
Sources: en.wikipedia.org
== GST-tags and the GST pull-down assay == GST can be added to a protein of interest to purify it from solution in a process known as a pull-down assay. This is accomplished by inserting the GST DNA coding sequence next to that which codes for the protein of interest. Thus, after transcription and translation, the GST protein and the protein of interest will be expressed together as a fusion protein. Because the GST protein has a strong binding affinity for GSH, beads coated with the compound can be added to the protein mixture; as a result, the protein of interest attached to the GST will stick to the beads, isolating the protein from the rest of those in solution. The beads are recovered and washed with free GSH to detach the protein of interest from the beads, resulting in a purified protein. This technique can be used to elucidate direct protein–protein interactions. A drawback of this assay is that the protein of interest is attached to GST, altering its native state. A GST-tag is often used to separate and purify proteins that contain the GST-fusion protein. The tag is 220 amino acids (roughly 26 kDa) in size, which, compared to tags such as the Myc-tag or the FLAG-tag, is quite large. It can be fused to either the N-terminus or C-terminus of a protein. In addition to functioning as a purification tag, GST acts as a chaperone for the attached protein, promoting its correct folding, as well as preventing it from becoming aggregated in inclusion bodies when expressed in bacteria.
=== Microbial metabolites === Microbes compete for living space and nutrients. To survive in these conditions, many microbes have developed abilities to prevent competing species from proliferating. Microbes are the main source of antimicrobial drugs. Streptomyces isolates have been such a valuable source of antibiotics, that they have been called medicinal molds. The classic example of an antibiotic discovered as a defense mechanism against another microbe is penicillin in bacterial cultures contaminated by Penicillium fungi in 1928.
Vancomycin is recommended to be administered in a dilute solution slowly, over at least 60 min (maximum rate of 10 mg/min for doses >500 mg) due to the high incidence of pain and thrombophlebitis and to avoid an infusion reaction known as vancomycin flushing reaction. This phenomenon has been often clinically referred to as "red man syndrome". The reaction usually appears within 4 to 10 min after the commencement or soon after the completion of an infusion and is characterized by flushing and/or an erythematous rash that affects the face, neck, and upper torso, attributed to the release of histamine from mast cells. This reaction is caused by the interaction of vancomycin with MRGPRX2, a GPCR-mediating IgE-independent mast cell degranulation. Less frequently, hypotension and angioedema occur. Symptoms may be treated or prevented with antihistamines, including diphenhydramine, and are less likely to occur with slow infusion.
== Applications of machine learning in peptide prediction == Machine learning and deep learning architectures are extensively utilized to classify, screen, and design peptides based on sequence- and structure-derived data. These computational approaches are particularly valuable when experimental screening is cost-prohibitive, time-consuming, or difficult to scale. A standard workflow typically involves dataset curation, the transformation of peptide sequences or structures into numerical features, model optimization, and rigorous performance validation. Commonly used representations include amino acid composition, physicochemical descriptors, substitution matrices, and learned embeddings derived from protein or peptide language models. These methodologies have been successfully applied across various functional classes, such as antimicrobial peptides, cell-penetrating peptides, and anticancer agents. Current challenges in the field include addressing dataset biases, establishing consistent benchmarking protocols, and improving the interpretability of complex "black-box" models.
==== Pancreatitis ==== The evidence suggesting a link between benzodiazepines (and Z-Drugs) and pancreatic inflammation is very sparse and limited to a few observational studies from Taiwan. A criticism of confounding can be applied to these findings as with the other controversial associations above. Further well-designed research from other populations, as well as a biologically plausible mechanism, is required to confirm this association.
Sources: en.wikipedia.org
measles outbreak in 2019, the Centers for Disease Control and Prevention stated that outbreaks are more likely in areas with pockets of unvaccinated residents. However, during the U.S. outbreak beginning in February 2025, the agency declined to publicize their updated expert assessment and forecasting model supporting this conclusion, thereby choosing not to alert clinicians and the public of being at specific risk in areas with low immunization rates. The vaccine has nonspecific effects such as preventing respiratory infections, that may be greater than those of measles prevention alone. These benefits are greater when the vaccine is given before one year of age. A high-titre vaccine resulted in worse outcomes in girls, and consequently is not recommended by the World Health Organization. The immune response to the measles vaccine can be impaired by the presence of parasitic infections such as helminthiasis.
What will happen after we enter to dispute interests of all kinds?""Peruvians are very funny, they have usurped two provinces from us (referring to Jaén and Maynas); four from Buenos Aires (referring to the provinces of Upper Peru) and they dispute Chiloé with Chile, and then they are afraid that they will be conquered, because the thief is always afraid of justice.""At this moment I just learned that in the [Colombian] Congress there are good opinions regarding Upper Peru. I call good those who are inclined not to deliver it to Peru, because that is the basis of our public right"It was even denounced that Bolivar had a final project to provoke a Total Dismemberment of Peru, because the opposition of the Peruvians to his political projects was latent and exaggeratedly feared by Bolívar, therefore, to dominate the Americas, he had a duty to further weaken Peru, being necessary to take away its hegemonic possibility against the neighboring republics in South America, so that he, as president for Life (with the right to name an heir), would rule over all and thus begin the Project of a Hispano-American Confederation (led by Gran Colombia after convoking the Congress of Panama), through the weakening of the Peruvian institutional framework for such purposes. So, he wanted a Federation of the Andes, which would unify Venezuela, Colombia, and Quito (later called Ecuador) with Peru and Bolivia, leaving Bolívar as president for life.
There are many synonyms in informal registers for human feces. Many are euphemistic, colloquial, or both; some are profane (such as shit), whereas most belong chiefly to child-directed speech (such as poo or poop) or to crude humor (such as turd). An example of an euphemistic term for feces is number two.
=== Factors === There are some factors that are closely related to the selectivity property of antimicrobial peptides, among which the cationic property contributes most. Since the surface of the bacterial membranes is more negatively charged than mammalian cells, antimicrobial peptides will show different affinities towards the bacterial membranes and mammalian cell membranes. In addition, there are also other factors that will affect the selectivity. It's well known that cholesterol is normally widely distributed in the mammalian cell membranes as a membrane stabilizing agent but absent in bacterial cell membranes (except when sequestered by H. pylori); and the presence of these cholesterols will also generally reduce the activities of the antimicrobial peptides, due either to stabilization of the lipid bilayer or to interactions between cholesterol and the peptide. So the cholesterol in mammalian cells will protect the cells from attack by the antimicrobial peptides. Besides, the transmembrane potential is well known to affect peptide-lipid interactions. There's an inside-negative transmembrane potential existing from the outer leaflet to the inner leaflet of the cell membranes and this inside-negative transmembrane potential will facilitate membrane permeabilization probably by facilitating the insertion of positively charged peptides into membranes. By comparison, the transmembrane potential of bacterial cells is more negative than that of normal mammalian cells, so bacterial membrane will be prone to be attacked by the positively charged antimicrobial peptides.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.